Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration (Q36619213)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2006
edit
Language Label Description Also known as
English
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
scientific article published on October 2006

    Statements

    Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration (English)
    0 references
    1 October 2006
    859-870

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit